Longevity & wellness clinics
Formalize multidisciplinary interpretation, reduce repeated manual synthesis and create a consistent longitudinal view across episodes.
Explore clinicsAXIS converts fragmented biomarker data into versioned, explainable and longitudinal representations of biological state. The deterministic Blood engine is functional; the architecture is designed to connect blood, fecal microbiota, urine biomarkers and metabolomics, genetics, wearables and phenotypic and contextual data through within-domain patterns and cross-patterns. Multimodal configurations are being developed for bounded partner pilots.
DBSI = Deterministic Biological State Index. An explainable 0–100 episode-level synthesis; higher values indicate lower modeled deviation within the configured AXIS module. It is not a diagnosis.
Sanitized public reconstruction of an output produced by the current deterministic engine. It is not the production interface, does not represent a patient and is not a clinical result.
AXIS adds a governed biological-state layer to the measurements, assays and professional workflows organizations already use.
Formalize multidisciplinary interpretation, reduce repeated manual synthesis and create a consistent longitudinal view across episodes.
Explore clinicsAdd a governed interpretation layer around one panel or a multimodal program, with white-label and integration pathways.
Explore labsExpose stable, versioned biological-state outputs to products, APIs and downstream analytics without weakening traceability.
Explore the platformThe current AXIS Core Blood environment executes the full deterministic hierarchy and exposes the resulting state, axes, confidence, coverage and version context. Public disclosure remains intentionally limited; deeper traceability is available through qualified access.
AXIS is designed to preserve the identity and provenance of each source while relating signals across blood, fecal microbiota, urine biomarkers and metabolomics, genetics, wearables and phenotypic and contextual data.
Source-specific signals remain attributable to the measurements and domain that produced them.
Cross-patterns encode explicit, versioned relationships whose contributing evidence comes from two or more input domains.
Blood analytics provide the current functional entry point for the deterministic Core.
Blood count, glucose regulation, lipids, liver, renal, inflammatory and iron-transport markers, with units, provenance and timing.
It can represent convergence, discordance or interaction while preserving the provenance, coverage and confidence of the contributing signals.
AXIS does not claim to reproduce the full complexity of human biology. It provides a more complete and inspectable representation than reviewing blood, microbiota, metabolomics, genetics or wearable reports independently. The multimodal cross-pattern configuration remains in development and requires validation within each defined use case.
Existing tests produce valuable data, but their relationships, conflicts and evolution across time often remain manual, inconsistent or opaque.
Blood, fecal microbiota, urine biomarkers and metabolomics, genetics, wearables and context arrive in different formats and interpretive frameworks.
High-value biological reasoning often lives in clinician memory, local notes or non-versioned workflows.
More testing accumulates, but persistence, direction and response remain weakly structured over time.
Black-box scores make it difficult to inspect evidence, govern changes or progress toward regulated uses.
AXIS creates a governed state layer between biological measurements and the applications built on top of them.
Biological measurements and authorized context are organized as one governed episode.
Blood markers, fecal microbiota, urine metabolomics, genetics and wearable data collected for the same analysis window.
The current engine, internal platform and future commercial surfaces share one deterministic architecture while retaining explicit lifecycle states, intended uses and evidence boundaries.
End-to-end deterministic inference from normalized parameters to patterns, blocks, axes and synthesis.
Explore +Operational backoffice for modules, parameters, patterns, blocks, axes, conflicts and traceability.
Explore +Version-aware professional output across parameters, patterns, blocks, axes and global synthesis.
Explore +Comparable episodes, persistence, direction of change and response over time.
Explore +Version-consistent cohort states, structured exports and governed partner integrations.
Explore +The deterministic engine executes the governed hierarchy from normalized laboratory parameters to patterns, blocks, four axes and episode synthesis.
Input: normalized blood parameters with provenance and version. Output: traceable patterns, blocks, axes, confidence, coverage and DBSI synthesis.
US wellness and laboratory pilots can generate commercial learning while medical modules retain separate evidence, quality and regulatory requirements.
Bounded pilots, provider-facing reports, white-label programs and progressive integration can test workflow value and commercial demand.
The medical pathway remains independently governed, with its own validation, quality-system and regulatory requirements.
AXIS has moved beyond concept risk, while external evidence, productization, integration and repeatable deployment remain the next value-creation steps.
Normalization, deterministic hierarchy, confidence, coherence, conflicts, axes, synthesis and traceability.
Scientific and clinical performance requires external evaluation under frozen, predefined protocols.
Patent, trademark, know-how, code and documentation protections are being formalized.
Medical, research and wellness modules retain separate rules, versions, claims and outputs.
AXIS is being developed around a proposed two-layer institutional architecture: an operating company intended to build, license and scale products and deployments, and a future independent governance layer that may protect the AXIS Charter, deterministic Core principles and scientific standards. The final legal structure is not yet constituted.
Explore scientific governanceAXIS was conceived to convert fragmented biomedical data into a governed, traceable representation built for professional utility, validation and scale.

Christopher combines clinical practice, structural reasoning and long-term product architecture. Engineering execution and specialist regulatory and IP support extend the founder-led scientific direction.
The strongest first engagement begins with one program, one user group, one evidence boundary and one output contract.